Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Glioma × Chloroquine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1 CNS 1

Conditions

Glioma 1 Chondrosarcoma 1 Cholangiocarcinoma 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1

Interventions

Temozolomide 25 Radiotherapy 10 Bevacizumab 10 Carboplatin 6 Irinotecan 5 pembrolizumab 4 Radiation 4 Nivolumab 4 IL13-PE38 4 temsirolimus 3 Surgical Procedures, Operative 3 Magnetic Resonance Spectroscopy 3 Immunotherapy, Adoptive 3 Erlotinib Hydrochloride 3 Aminolevulinic Acid 3 trametinib 2 olaparib 2 lutetium Lu 177 dotatate 2 fludarabine 2 dabrafenib 2 abemaciclib 2 Vorinostat 2 Transurethral Resection of Bladder 2 Sirolimus 2 Radiotherapy, Intensity-Modulated 2 Radiosurgery 2 Imatinib Mesylate 2 Flucytosine 2 Cyclophosphamide 2 Chlorotoxin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02496741 2020-01-09

MACIST

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 1/2 Completed

CNSGastrointestinalSarcoma

Chondrosarcoma, Glioma, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡